UniProt ID | NFH_HUMAN | |
---|---|---|
UniProt AC | P12036 | |
Protein Name | Neurofilament heavy polypeptide | |
Gene Name | NEFH | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1026 | |
Subcellular Localization | Cytoplasm . | |
Protein Description | Neurofilaments usually contain three intermediate filament proteins: L, M, and H which are involved in the maintenance of neuronal caliber. NF-H has an important function in mature axons that is not subserved by the two smaller NF proteins.. | |
Protein Sequence | MMSFGGADALLGAPFAPLHGGGSLHYALARKGGAGGTRSAAGSSSGFHSWTRTSVSSVSASPSRFRGAGAASSTDSLDTLSNGPEGCMVAVATSRSEKEQLQALNDRFAGYIDKVRQLEAHNRSLEGEAAALRQQQAGRSAMGELYEREVREMRGAVLRLGAARGQLRLEQEHLLEDIAHVRQRLDDEARQREEAEAAARALARFAQEAEAARVDLQKKAQALQEECGYLRRHHQEEVGELLGQIQGSGAAQAQMQAETRDALKCDVTSALREIRAQLEGHAVQSTLQSEEWFRVRLDRLSEAAKVNTDAMRSAQEEITEYRRQLQARTTELEALKSTKDSLERQRSELEDRHQADIASYQEAIQQLDAELRNTKWEMAAQLREYQDLLNVKMALDIEIAAYRKLLEGEECRIGFGPIPFSLPEGLPKIPSVSTHIKVKSEEKIKVVEKSEKETVIVEEQTEETQVTEEVTEEEEKEAKEEEGKEEEGGEEEEAEGGEEETKSPPAEEAASPEKEAKSPVKEEAKSPAEAKSPEKEEAKSPAEVKSPEKAKSPAKEEAKSPPEAKSPEKEEAKSPAEVKSPEKAKSPAKEEAKSPAEAKSPEKAKSPVKEEAKSPAEAKSPVKEEAKSPAEVKSPEKAKSPTKEEAKSPEKAKSPEKAKSPEKEEAKSPEKAKSPVKAEAKSPEKAKSPVKAEAKSPEKAKSPVKEEAKSPEKAKSPVKEEAKSPEKAKSPVKEEAKTPEKAKSPVKEEAKSPEKAKSPEKAKTLDVKSPEAKTPAKEEARSPADKFPEKAKSPVKEEVKSPEKAKSPLKEDAKAPEKEIPKKEEVKSPVKEEEKPQEVKVKEPPKKAEEEKAPATPKTEEKKDSKKEEAPKKEAPKPKVEEKKEPAVEKPKESKVEAKKEEAEDKKKVPTPEKEAPAKVEVKEDAKPKEKTEVAKKEPDDAKAKEPSKPAEKKEAAPEKKDTKEEKAKKPEEKPKTEAKAKEDDKTLSKEPSKPKAEKAEKSSSTDQKDSKPPEKATEDKAAKGK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
31 | Ubiquitination | LHYALARKGGAGGTR HHHHHHHCCCCCCCC | 56.97 | - | |
39 | Phosphorylation | GGAGGTRSAAGSSSG CCCCCCCCCCCCCCC | 23.47 | 28857561 | |
43 | Phosphorylation | GTRSAAGSSSGFHSW CCCCCCCCCCCCCCC | 19.32 | 28857561 | |
44 | Phosphorylation | TRSAAGSSSGFHSWT CCCCCCCCCCCCCCC | 33.30 | 27732954 | |
53 | O-linked_Glycosylation | GFHSWTRTSVSSVSA CCCCCCCCEECCEEC | 26.55 | - | |
53 | O-linked_Glycosylation | GFHSWTRTSVSSVSA CCCCCCCCEECCEEC | 26.55 | 8702840 | |
53 | Phosphorylation | GFHSWTRTSVSSVSA CCCCCCCCEECCEEC | 26.55 | 26434776 | |
54 | O-linked_Glycosylation | FHSWTRTSVSSVSAS CCCCCCCEECCEECC | 19.40 | 30379171 | |
54 | Phosphorylation | FHSWTRTSVSSVSAS CCCCCCCEECCEECC | 19.40 | 27732954 | |
54 | O-linked_Glycosylation | FHSWTRTSVSSVSAS CCCCCCCEECCEECC | 19.40 | 8702840 | |
56 | O-linked_Glycosylation | SWTRTSVSSVSASPS CCCCCEECCEECCCC | 25.45 | 30379171 | |
56 | O-linked_Glycosylation | SWTRTSVSSVSASPS CCCCCEECCEECCCC | 25.45 | 8702840 | |
56 | Phosphorylation | SWTRTSVSSVSASPS CCCCCEECCEECCCC | 25.45 | 26434776 | |
57 | Phosphorylation | WTRTSVSSVSASPSR CCCCEECCEECCCCC | 20.24 | 26434776 | |
59 | Phosphorylation | RTSVSSVSASPSRFR CCEECCEECCCCCCC | 25.61 | 30619164 | |
61 | Phosphorylation | SVSSVSASPSRFRGA EECCEECCCCCCCCC | 18.85 | 28857561 | |
63 | Phosphorylation | SSVSASPSRFRGAGA CCEECCCCCCCCCCC | 41.37 | 30619164 | |
72 | Phosphorylation | FRGAGAASSTDSLDT CCCCCCCCCCCCHHH | 32.98 | 27732954 | |
73 | Phosphorylation | RGAGAASSTDSLDTL CCCCCCCCCCCHHHH | 31.35 | 27732954 | |
74 | Phosphorylation | GAGAASSTDSLDTLS CCCCCCCCCCHHHHH | 27.41 | 27732954 | |
76 | Phosphorylation | GAASSTDSLDTLSNG CCCCCCCCHHHHHCC | 28.38 | 28857561 | |
79 | Phosphorylation | SSTDSLDTLSNGPEG CCCCCHHHHHCCCCC | 37.06 | 28857561 | |
81 | Phosphorylation | TDSLDTLSNGPEGCM CCCHHHHHCCCCCEE | 41.66 | 27732954 | |
94 | Phosphorylation | CMVAVATSRSEKEQL EEEEEECCCCHHHHH | 24.87 | 24425749 | |
98 | Ubiquitination | VATSRSEKEQLQALN EECCCCHHHHHHHHH | 52.59 | 21987572 | |
111 | Phosphorylation | LNDRFAGYIDKVRQL HHHHHHHHHHHHHHH | 11.52 | - | |
124 | Phosphorylation | QLEAHNRSLEGEAAA HHHHHCCCHHHHHHH | 35.77 | 27732954 | |
229 | Phosphorylation | ALQEECGYLRRHHQE HHHHHHCHHHHHHHH | 14.53 | 29978859 | |
264 | Ubiquitination | AETRDALKCDVTSAL HHHHHHHHCHHHHHH | 30.06 | 21987572 | |
268 | O-linked_Glycosylation | DALKCDVTSALREIR HHHHCHHHHHHHHHH | 8.60 | 30379171 | |
301 | Phosphorylation | RVRLDRLSEAAKVNT HHHHHHHHHHHHCCH | 26.53 | 23403867 | |
336 | Ubiquitination | TTELEALKSTKDSLE HHHHHHHHHHHHHHH | 64.23 | 29967540 | |
337 | Phosphorylation | TELEALKSTKDSLER HHHHHHHHHHHHHHH | 41.35 | - | |
347 | Phosphorylation | DSLERQRSELEDRHQ HHHHHHHHHHHHHHH | 37.89 | - | |
385 | Phosphorylation | MAAQLREYQDLLNVK HHHHHHHHHHHHCHH | 10.82 | - | |
402 | Phosphorylation | LDIEIAAYRKLLEGE HHHHHHHHHHHHCCC | 10.16 | - | |
412 | Methylation | LLEGEECRIGFGPIP HHCCCCCEECCCCCC | 35.03 | - | |
421 | Phosphorylation | GFGPIPFSLPEGLPK CCCCCCCCCCCCCCC | 37.35 | - | |
421 | O-linked_Glycosylation | GFGPIPFSLPEGLPK CCCCCCCCCCCCCCC | 37.35 | 30379171 | |
431 | Phosphorylation | EGLPKIPSVSTHIKV CCCCCCCCCCEEEEE | 31.97 | 28857561 | |
501 | Phosphorylation | AEGGEEETKSPPAEE HCCCCCCCCCCCHHH | 39.85 | 18510355 | |
503 | Phosphorylation | GGEEETKSPPAEEAA CCCCCCCCCCHHHHC | 43.46 | 18510355 | |
511 | Phosphorylation | PPAEEAASPEKEAKS CCHHHHCCHHHHCCC | 40.41 | 30177828 | |
518 | Phosphorylation | SPEKEAKSPVKEEAK CHHHHCCCCCCHHHC | 41.81 | 18510355 | |
526 | Phosphorylation | PVKEEAKSPAEAKSP CCCHHHCCHHHHCCC | 36.07 | 18510355 | |
531 | Ubiquitination | AKSPAEAKSPEKEEA HCCHHHHCCCCHHHC | 59.03 | - | |
532 | Phosphorylation | KSPAEAKSPEKEEAK CCHHHHCCCCHHHCC | 45.39 | 21955146 | |
532 | O-linked_Glycosylation | KSPAEAKSPEKEEAK CCHHHHCCCCHHHCC | 45.39 | 30379171 | |
540 | Phosphorylation | PEKEEAKSPAEVKSP CCHHHCCCCCCCCCH | 36.07 | 30177828 | |
546 | Phosphorylation | KSPAEVKSPEKAKSP CCCCCCCCHHHCCCC | 43.39 | 22167270 | |
552 | Phosphorylation | KSPEKAKSPAKEEAK CCHHHCCCCCHHHHC | 34.64 | 26657352 | |
560 | Phosphorylation | PAKEEAKSPPEAKSP CCHHHHCCCCCCCCC | 53.38 | 20886841 | |
565 | Ubiquitination | AKSPPEAKSPEKEEA HCCCCCCCCCCHHHC | 65.95 | - | |
566 | Phosphorylation | KSPPEAKSPEKEEAK CCCCCCCCCCHHHCC | 45.39 | 20886841 | |
574 | Phosphorylation | PEKEEAKSPAEVKSP CCHHHCCCCCCCCCH | 36.07 | 30177828 | |
580 | Phosphorylation | KSPAEVKSPEKAKSP CCCCCCCCHHHCCCC | 43.39 | 22167270 | |
586 | Phosphorylation | KSPEKAKSPAKEEAK CCHHHCCCCCHHHCC | 34.64 | 26657352 | |
594 | Phosphorylation | PAKEEAKSPAEAKSP CCHHHCCCHHHHCCH | 36.07 | 23403867 | |
600 | Phosphorylation | KSPAEAKSPEKAKSP CCHHHHCCHHHCCCC | 45.39 | 20815410 | |
606 | Phosphorylation | KSPEKAKSPVKEEAK CCHHHCCCCCCHHCC | 39.52 | 18510355 | |
614 | Phosphorylation | PVKEEAKSPAEAKSP CCCHHCCCHHHHCCC | 36.07 | 18510355 | |
620 | Phosphorylation | KSPAEAKSPVKEEAK CCHHHHCCCCCHHCC | 41.81 | 23898821 | |
628 | Phosphorylation | PVKEEAKSPAEVKSP CCCHHCCCCCCCCCH | 36.07 | 30177828 | |
634 | Phosphorylation | KSPAEVKSPEKAKSP CCCCCCCCHHHCCCC | 43.39 | 22167270 | |
640 | Phosphorylation | KSPEKAKSPTKEEAK CCHHHCCCCCHHHHC | 42.53 | 18510355 | |
642 | O-linked_Glycosylation | PEKAKSPTKEEAKSP HHHCCCCCHHHHCCH | 59.17 | 30379171 | |
648 | Phosphorylation | PTKEEAKSPEKAKSP CCHHHHCCHHHCCCH | 45.39 | 18510355 | |
648 | O-linked_Glycosylation | PTKEEAKSPEKAKSP CCHHHHCCHHHCCCH | 45.39 | 30379171 | |
654 | Phosphorylation | KSPEKAKSPEKAKSP CCHHHCCCHHHHCCC | 43.05 | 18510355 | |
657 | Acetylation | EKAKSPEKAKSPEKE HHCCCHHHHCCCCHH | 65.58 | 18526003 | |
659 | Acetylation | AKSPEKAKSPEKEEA CCCHHHHCCCCHHHC | 77.07 | 18526013 | |
659 | Ubiquitination | AKSPEKAKSPEKEEA CCCHHHHCCCCHHHC | 77.07 | - | |
660 | Phosphorylation | KSPEKAKSPEKEEAK CCHHHHCCCCHHHCC | 43.05 | 18510355 | |
662 | Phosphorylation | PEKAKSPEKEEAKSP HHHHCCCCHHHCCCH | 78.99 | 18510355 | |
663 | Acetylation | EKAKSPEKEEAKSPE HHHCCCCHHHCCCHH | 65.32 | 18526023 | |
668 | Phosphorylation | PEKEEAKSPEKAKSP CCHHHCCCHHHHCCC | 45.39 | 18510355 | |
674 | Phosphorylation | KSPEKAKSPVKAEAK CCHHHHCCCCCCCCC | 39.52 | 18510355 | |
676 | Phosphorylation | PEKAKSPVKAEAKSP HHHHCCCCCCCCCCH | 13.65 | 18510355 | |
682 | Phosphorylation | PVKAEAKSPEKAKSP CCCCCCCCHHHCCCC | 45.39 | 18510355 | |
688 | Phosphorylation | KSPEKAKSPVKAEAK CCHHHCCCCCCCCCC | 39.52 | 18510355 | |
690 | Phosphorylation | PEKAKSPVKAEAKSP HHHCCCCCCCCCCCH | 13.65 | 18510355 | |
696 | Phosphorylation | PVKAEAKSPEKAKSP CCCCCCCCHHHHCCC | 45.39 | 18510355 | |
702 | Phosphorylation | KSPEKAKSPVKEEAK CCHHHHCCCCHHHHC | 39.52 | 25072903 | |
704 | Phosphorylation | PEKAKSPVKEEAKSP HHHHCCCCHHHHCCH | 18.40 | 18510355 | |
710 | Phosphorylation | PVKEEAKSPEKAKSP CCHHHHCCHHHHCCC | 45.39 | 21955146 | |
716 | Phosphorylation | KSPEKAKSPVKEEAK CCHHHHCCCCHHHHC | 39.52 | 25072903 | |
718 | Phosphorylation | PEKAKSPVKEEAKSP HHHHCCCCHHHHCCH | 18.40 | 18510355 | |
724 | Phosphorylation | PVKEEAKSPEKAKSP CCHHHHCCHHHHCCC | 45.39 | 21955146 | |
730 | Phosphorylation | KSPEKAKSPVKEEAK CCHHHHCCCCCHHCC | 39.52 | 18510355 | |
732 | Phosphorylation | PEKAKSPVKEEAKTP HHHHCCCCCHHCCCH | 18.40 | 18510355 | |
738 | Phosphorylation | PVKEEAKTPEKAKSP CCCHHCCCHHHHCCC | 43.67 | 18510355 | |
744 | Phosphorylation | KTPEKAKSPVKEEAK CCHHHHCCCCHHHHC | 39.52 | 18510355 | |
746 | Phosphorylation | PEKAKSPVKEEAKSP HHHHCCCCHHHHCCH | 18.40 | 18510355 | |
752 | Phosphorylation | PVKEEAKSPEKAKSP CCHHHHCCHHHCCCH | 45.39 | 21955146 | |
758 | Phosphorylation | KSPEKAKSPEKAKTL CCHHHCCCHHHHCCC | 43.05 | 18510355 | |
763 | Phosphorylation | AKSPEKAKTLDVKSP CCCHHHHCCCCCCCC | 61.77 | 18510355 | |
769 | Phosphorylation | AKTLDVKSPEAKTPA HCCCCCCCCCCCCCC | 28.02 | 26033855 | |
774 | Phosphorylation | VKSPEAKTPAKEEAR CCCCCCCCCCHHHHC | 35.21 | 21857030 | |
776 | Phosphorylation | SPEAKTPAKEEARSP CCCCCCCCHHHHCCH | 36.80 | 27251275 | |
782 | Phosphorylation | PAKEEARSPADKFPE CCHHHHCCHHHHCCH | 31.33 | 26033855 | |
787 | Phosphorylation | ARSPADKFPEKAKSP HCCHHHHCCHHHCCC | 10.99 | 18510355 | |
793 | Phosphorylation | KFPEKAKSPVKEEVK HCCHHHCCCCCHHCC | 39.52 | 28348404 | |
795 | Phosphorylation | PEKAKSPVKEEVKSP CHHHCCCCCHHCCCH | 18.40 | 18510355 | |
801 | Phosphorylation | PVKEEVKSPEKAKSP CCCHHCCCHHHHCCC | 43.39 | 30177828 | |
807 | Phosphorylation | KSPEKAKSPLKEDAK CCHHHHCCCCHHCCC | 40.08 | 23312004 | |
822 | Phosphorylation | APEKEIPKKEEVKSP CCCCCCCCHHHCCCC | 77.73 | 18510355 | |
828 | Phosphorylation | PKKEEVKSPVKEEEK CCHHHCCCCCCCCCC | 39.85 | 18510355 | |
889 | Ubiquitination | EKKEPAVEKPKESKV CCCCCCCCCCCHHCC | 66.79 | 29967540 | |
894 | Phosphorylation | AVEKPKESKVEAKKE CCCCCCHHCCHHHHH | 48.40 | 25332170 | |
905 | Phosphorylation | AKKEEAEDKKKVPTP HHHHHHHHHCCCCCC | 75.11 | 27251275 | |
907 | Acetylation | KEEAEDKKKVPTPEK HHHHHHHCCCCCCCC | 71.91 | 7469317 | |
908 | Acetylation | EEAEDKKKVPTPEKE HHHHHHCCCCCCCCC | 60.22 | 7469325 | |
911 | Phosphorylation | EDKKKVPTPEKEAPA HHHCCCCCCCCCCCC | 47.25 | 20886841 | |
942 | Phosphorylation | AKKEPDDAKAKEPSK HHCCCCCHHHCCCCC | 22.53 | - | |
948 | Phosphorylation | DAKAKEPSKPAEKKE CHHHCCCCCHHHHHH | 52.98 | 21828286 | |
993 | Phosphorylation | KTLSKEPSKPKAEKA CCCCCCCCCHHHHHH | 63.78 | - | |
1005 | Phosphorylation | EKAEKSSSTDQKDSK HHHHHCCCCCCCCCC | 42.99 | 27794612 | |
1006 | Phosphorylation | KAEKSSSTDQKDSKP HHHHCCCCCCCCCCC | 44.38 | 27794612 | |
1011 | Phosphorylation | SSTDQKDSKPPEKAT CCCCCCCCCCCHHHH | 54.84 | 27794612 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
503 | S | Phosphorylation | Kinase | GSK3B | P49841 | PSP |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of NFH_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NFH_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
PKN1_HUMAN | PKN1 | physical | 8621664 | |
NFL_HUMAN | NEFL | physical | 9388258 | |
AINX_HUMAN | INA | physical | 28514442 | |
NFL_HUMAN | NEFL | physical | 28514442 | |
NFM_HUMAN | NEFM | physical | 28514442 | |
TARB1_HUMAN | TARBP1 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
105400 | Amyotrophic lateral sclerosis (ALS) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...